BAY2253651
/ Bayer
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
September 18, 2021
BAY 2253651 for the treatment of obstructive sleep apnea: a multi-center, double-blind, randomized controlled trial (SANDMAN).
(PubMed, Eur Respir J)
- No abstract available
Clinical • Journal • Obstructive Sleep Apnea • Respiratory Diseases • Sleep Disorder
September 25, 2019
SANDMAN: Obstructive Sleep Apnea (OSA) Treated With a Potassium Channel Inhibitor
(clinicaltrials.gov)
- P2; N=34; Completed; Sponsor: Bayer; Active, not recruiting ➔ Completed
Clinical • Trial completion
1 to 2
Of
2
Go to page
1